Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGS 21680 is a chemical compound that acts as a selective agonist for both adenosine and its A2A receptor, demonstrating a binding affinity (K i) of 27 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,520.00 | |
50 mg | 8-10 weeks | $ 1,980.00 | |
100 mg | 8-10 weeks | $ 2,500.00 |
Description | CGS 21680 is a chemical compound that acts as a selective agonist for both adenosine and its A2A receptor, demonstrating a binding affinity (K i) of 27 nM. |
In vitro | CGS21680 notably increases the levels of CD39 and CD73 expression and enhances the breakdown of adenosine triphosphate (ATP) into adenosine [1]. While CGS21680 at a concentration of 10 nM demonstrates minimal survival activity independently, this activity is substantially boosted when combined with the phosphodiesterase inhibitor, IBMX. The enhancement of motoneuron survival by CGS21680 is attributed to the combined influence of the adenylate cyclase-cAMP-PKA pathway and the transactivation of neurotrophin receptors [4]. |
In vivo | CGS21680 (1 mg/kg/i.p.) administration enhances the progression of experimental autoimmune neuritis (EAN) in bovine peripheral myelin-induced Lewis rats by worsening the condition. This aggravation involves a decrease in CD4+ Foxp3+ T cells and an increase in CD4+ CXCR5+ T cells, B cells, dendritic cells, and antigen-specific autoantibodies, likely due to CGS21680's suppression of IL-2. At a lower dose (0.1 mg/kg, i.p.), CGS21680 temporarily raises heart rate without affecting blood pressure in rats, and at an even lower dose (0.01 mg/kg), it has no impact on heart rate or blood pressure. Post-transient middle cerebral artery occlusion (MCAo), CGS21680, at both dosages, offers protection against neurological deficits for up to 7 days, reduces microgliosis and astrogliosis, and enhances myelin organization in the striatum as well as the cytoarchitecture of the ischemic cortex and striatum. Additionally, two days post-transient MCAo, it diminishes the number of infiltrated granulocytes in ischemic tissue. |
Molecular Weight | 499.52 |
Formula | C23H29N7O6 |
CAS No. | 120225-54-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGS 21680 120225-54-9 CGS-21680 CGS21680 inhibitor inhibit